Guardant Health, Inc. revenue breakdown overview

Guardant Health, Inc. revenue for the last year amounted to 563.95 M USD, the most of which — 514.25 M USD — came from its highest performing source at the moment, Precision Oncology Testing, the year earlier bringing 392.05 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Guardant Health, Inc. 526.52 M USD, and the year before that — 420.62 M USD.